Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pharmacovigilance01:19

Pharmacovigilance

1.3K
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
1.3K
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

214
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
214
Causality in Epidemiology01:21

Causality in Epidemiology

1.1K
Causality or causation is a fundamental concept in epidemiology, vital for understanding the relationships between various factors and health outcomes. Despite its importance, there's no single, universally accepted definition of causality within the discipline. Drawing from a systematic review, causality in epidemiology encompasses several definitions, including production, necessary and sufficient, sufficient-component, counterfactual, and probabilistic models. Each has its strengths and...
1.1K
Analysis of Population Pharmacokinetic Data01:12

Analysis of Population Pharmacokinetic Data

499
Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
499
Pharmacokinetic Models: Overview01:20

Pharmacokinetic Models: Overview

1.4K
Pharmacokinetic models utilize mathematical analysis to achieve a detailed quantitative understanding of a drug's life cycle within the body. They are instrumental in simulating a drug's pharmacokinetic parameters, predicting drug concentrations over time, optimizing dosage regimens, linking concentrations with pharmacologic activity, and estimating potential toxicity.
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal...
1.4K
Analysis Methods of Pharmacokinetic Data: Model and Model-Independent Approaches01:14

Analysis Methods of Pharmacokinetic Data: Model and Model-Independent Approaches

290
Drug disposition in the body is a complex process and can be studied using two major approaches: the model and the model-independent approaches.
The model approach uses mathematical models to describe changes in drug concentration over time. Pharmacokinetic models help characterize drug behavior in patients, predict drug concentration in the body fluids, calculate optimum dosage regimens, and evaluate the risk of toxicity. However, ensuring that the model fits the experimental data accurately...
290

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

GANomics: bridging legacy and modern transcriptomic platforms for clinical applications.

NPJ genomic medicine·2026
Same author

SARS-CoV-2 Spike Protein's Structural Dynamics Affect the Activity of the Bebtelovimab Antibody.

Journal of chemical information and modeling·2026
Same author

Therapists' Experiences of Delivering Therapy to Children Seeking Refuge and Asylum: A Qualitative Study.

Clinical child psychology and psychiatry·2026
Same author

Integrating in vitro and in silico NAMs for enhanced prediction of drug-induced liver injury.

Drug discovery today·2026
Same author

Safety considerations for cereblon-recruiting targeted protein degraders.

Nature reviews. Drug discovery·2026
Same author

Cohort Profile: Our Future-the longitudinal study of young people in England born in 1998-99.

International journal of epidemiology·2026

Related Experiment Video

Updated: Nov 1, 2025

Evidence-based Knowledge Synthesis and Hypothesis Validation: Navigating Biomedical Knowledge Bases via Explainable AI and Agentic Systems
05:47

Evidence-based Knowledge Synthesis and Hypothesis Validation: Navigating Biomedical Knowledge Bases via Explainable AI and Agentic Systems

Published on: June 13, 2025

805

InferBERT: A Transformer-Based Causal Inference Framework for Enhancing Pharmacovigilance.

Xingqiao Wang1, Xiaowei Xu1, Weida Tong2

  • 1Department of Information Science, University of Arkansas at Little Rock, Little Rock, AR, United States.

Frontiers in Artificial Intelligence
|June 17, 2021
PubMed
Summary

InferBERT, a new causal inference model, integrates ALBERT and Do-calculus to identify causes of clinical events from text. This approach enhances pharmacovigilance by inferring causality, improving healthcare outcomes.

Keywords:
artificial intelligencecausal inferencelanguage modelsnatural language processingpharmacovigilance

More Related Videos

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System
05:10

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System

Published on: December 11, 2016

9.9K
Author Spotlight: A Pharmacodissection Approach to Uncover Mechanisms in Cardiovascular Disease Risk Populations
08:21

Author Spotlight: A Pharmacodissection Approach to Uncover Mechanisms in Cardiovascular Disease Risk Populations

Published on: July 21, 2023

1.6K

Related Experiment Videos

Last Updated: Nov 1, 2025

Evidence-based Knowledge Synthesis and Hypothesis Validation: Navigating Biomedical Knowledge Bases via Explainable AI and Agentic Systems
05:47

Evidence-based Knowledge Synthesis and Hypothesis Validation: Navigating Biomedical Knowledge Bases via Explainable AI and Agentic Systems

Published on: June 13, 2025

805
Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System
05:10

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System

Published on: December 11, 2016

9.9K
Author Spotlight: A Pharmacodissection Approach to Uncover Mechanisms in Cardiovascular Disease Risk Populations
08:21

Author Spotlight: A Pharmacodissection Approach to Uncover Mechanisms in Cardiovascular Disease Risk Populations

Published on: July 21, 2023

1.6K

Area of Science:

  • Artificial Intelligence
  • Biomedical Informatics
  • Causal Inference

Background:

  • Transformer-based language models excel in NLP but lack causal inference capabilities.
  • Causality is crucial for pharmacovigilance and healthcare decision-making.
  • Current models cannot determine the cause of clinical outcomes.

Purpose of the Study:

  • To develop an innovative causal inference model, InferBERT.
  • To integrate ALBERT and Judea Pearl's Do-calculus for pharmacovigilance.
  • To address the need for causality inference in clinical outcome analysis.

Main Methods:

  • Proposed InferBERT model integrating ALBERT and Do-calculus.
  • Evaluation using FDA Adverse Event Reporting System (FAERS) data.
  • Case studies: Analgesics-related acute liver failure and Tramadol-related mortalities.
  • Causal tree generation using a recursive do-calculus algorithm.
  • Robustness assessment for reproducibility.

Main Results:

  • InferBERT achieved accuracies of 0.78 for acute liver failure and 0.95 for mortality.
  • Inferred causes aligned with existing clinical knowledge.
  • Causal trees enhanced understanding of causality.
  • High reproducibility demonstrated through robustness assessment.

Conclusions:

  • InferBERT successfully predicts clinical events and infers their causes.
  • The model establishes causal effects from text-based observational data.
  • InferBERT is a promising tool for understanding intrinsic causality in healthcare.